1. Articles from PR Newswire

    prnewswire.com

  2. 1-24 of 89 1 2 3 4 »
    1. 66% of diagnostic biopsies for common skin cancer can be avoided using Michelson Diagnostics' VivoSight OCT laser scanner

      66% of diagnostic biopsies for common skin cancer can be avoided using Michelson Diagnostics' VivoSight OCT laser scanner

      A major study published in leading cancer journal, The Lancet Oncology 1 have ground-breaking findings on Michelson Diagnostics, the UK based medical device company that use multi-beam Optical Coherence Tomography ('OCT') technology, which can transform patient's treatment and care of basal cell carcinomas (BCC). It was concluded that OCT-guided diagnosis, when compared to a standard punch biopsy could reduce the number of consultations and invasive procedures by a massive 66%. Professor Klara Mosterd performing an OCT scan on a patient’s lesion. Stitched skin biopsy wound Approximately 75% of skin cancers diagnosed in the UK are basal cell carcinomas ...

      Read Full Article
    2. Remidio's Medios AI shows significant promise in last-mile Screening for Referable Glaucoma

      Remidio's Medios AI shows significant promise in last-mile Screening for Referable Glaucoma

      Remidio Inc , alongside Aravind Eye Hospital (AEH), Pondicherry, and Narayana Nethralaya (NN), Bangalore , announced the results of a landmark clinical trial that can help revolutionize the detection of Referable Glaucoma. The integrated solution provides an instant report in contexts where there are no specialists. It consists of Remidio's Fundus on Phone , an imaging device that captures images of the retina without pupil dilation, and Remidio's Medios Referable Glaucoma AI, an integrated offline AI algorithm that requires no internet for inferencing. The AI looks beyond the cup-to-disc ratio and detects structural changes in the optic nerve head and surrounding ...

      Read Full Article
    3. PhotoniCare Announces ISO 13485:2016 Certification

      PhotoniCare Announces ISO 13485:2016 Certification

      PhotoniCare, Inc.—a company revolutionizing frontline care with the OtoSight Middle Ear Scope that uses OCT technology to increase the objective accuracy of fluid assessment in the middle ear—announced that they have successfully completed their ISO 13485:2016 certification today. ISO 13485:2016 is an internationally recognized quality standard that specifies requirements for a quality management system used by an organization demonstrating its ability to provide medical devices and related services that consistently meet strict regulatory and customer requirements. The Quality Management System PhotoniCare utilizes to design, manufacture, and service OtoSight Middle Ear Scopes has officially been audited and ...

      Read Full Article
    4. Clinical Trials Critical for the Evaluation of Advanced Medical Imaging Tools

      Clinical Trials Critical for the Evaluation of Advanced Medical Imaging Tools

      Image-guided surgery offers surgeons greater control of the procedure and real-time feedback, thus providing better outcomes for patients. Accuracy in surgical procedures is critical for serious or life-threatening conditions, such as cancer, and medical technology companies are providing imaging tools to help surgeons deliver better results to their patients. Companies such as Perimeter Medical Imaging AI (TSXV:PINK), Butterfly Network (NYSE: BFLY ), ENDRA Life Sciences Inc. (NASDAQ: NDRA ), Asensus Surgical Inc. (NYSE: ASXC ), and Avinger Inc. (NASDAQ: AVGR ) have engaged in the research and development of advanced imaging tools for use in different procedures. In addition to the development of ...

      Read Full Article
    5. Nanoscope® team conferred Phase II Retinal Organoid Challenge (ROC) award by National Institute of Health

      Nanoscope® team conferred Phase II Retinal Organoid Challenge (ROC) award by National Institute of Health

      To meet the advance challenge for generating a physiologically relevant three-dimensional (3D) retinal organoid, Nanoscope researchers® in collaboration with University of Colorado, and Miami University were recently awarded the top prize from... We are also advancing OCT guided targeted laser microirradiation technology for creating models of degenerative eye diseases such as Retinitis Pigmentosa (RP) and dry age-related macular degeneration (dry-AMD) as well as for targeted delivery of therapeutic genes," said Sulagna Bhattacharya , CEO of Nanoscope.

      Read Full Article
    6. ITRI Exhibits E-Health Monitoring and Inspection Innovations at CES 2021

      ITRI Exhibits E-Health Monitoring and Inspection Innovations at CES 2021

      ITRI developed the Handheld Skin Quality Optical Coherence Tomography system to replace the conventional approach of an invasive biopsy for examining tissue underneath the skin. It is the first handheld optical coherence tomography (OCT) system that analyzes subsurface skin structures and detects collagen distribution in the dermis layer. The technology incorporates a built-in skin quality analysis model, AI, and anti-shake image capturing technology to evaluate skin quality within 10 seconds. It weighs less than 400 grams (14 ounces), allowing users to operate the device with one hand. This innovation is used for medical purposes and provides valid scientific proof for ...

      Read Full Article
    7. ITRI Exhibits Innovations in AI, Robotics and e-Health at CES 2021

      ITRI Exhibits Innovations in AI, Robotics and e-Health at CES 2021

      ITRI's e-health monitoring and inspection technologies at CES 2021 include: The Handheld Skin Quality Optical Coherence Tomography analyzes skin quality by rapid high-resolution 3D imaging of skin structure. The device combines an opto-mechanical-electronics controller and an image processor to provide 3D optical biopsy using a broadband near-infrared light source.

      Read Full Article
    8. Ping An Research on AI Applications for Retinal Imaging Selected at Top International Medical Imaging Conference ISBI

      Ping An Research on AI Applications for Retinal Imaging Selected at Top International Medical Imaging Conference ISBI

      Ping An Insurance (Group) Company of China , Ltd. (hereafter "Ping An", the "Company" or the "Group", HKEX: 02318; SSE: 601318) announced today that five papers related to artificial intelligence (AI) technology in ophthalmic imaging by its smart city's smart health care team (Ping An Smart Healthcare) have been accepted by the top international medical imaging conference, the International Symposium on Biomedical Imaging (ISBI) 2020. ISBI is sponsored by the Institute of Electrical and Electronics Engineers (IEEE). The Ping An papers cover various smart tasks related to the diagnosis of eye diseases, including quality control, screening, lesion detection, segmentation and ...

      Read Full Article
    9. Optovue Introduces NetVue™ Cloud Image Management Solutions at the American Academy of Ophthalmology (AAO) Annual Meeting

      Optovue Introduces NetVue™ Cloud Image Management Solutions at the American Academy of Ophthalmology (AAO) Annual Meeting

      Optovue , the global leader in the development of optical coherence tomography (OCT) and OCT angiography (OCTA), will introduce NetVue™ Cloud image management software at AAO 2019 in San Francisco , October 12-15 , 2019. The NetVue software provides quick access to patients' images and data on a single screen, eliminating the need to open device-specific applications. Unlike other solutions on the market, there is no gateway application required, so images can be viewed anytime and from any device directly from any web browser. And cloud-based storage keeps patients' images and data safe and secure. "As medical practices continue to add imaging devices ...

      Read Full Article
      Mentions: Visionix
    10. ZEISS to showcase advancements in digital and surgical technology at ESCRS 2019

      ZEISS to showcase advancements in digital and surgical technology at ESCRS 2019

      During the 2019 European Society of Cataract and Refractive Surgery (ESCRS) Annual Meeting in Paris , ZEISS Medical Technology Segment will present new technologies advancing the digitalization of eye care and high-resolution imaging, helping doctors maximize clinical efficiency and performance. ZEISS ARTEVO 800 ZEISS CIRRUS 6000 including application ZEISS SL 800

      Read Full Article
    11. Non-Invasive Longitudinal Imaging of the Developing Eye

      Non-Invasive Longitudinal Imaging of the Developing Eye

      n article published in Experimental Biology and Medicine (Volume 244, Issue 10, July, 2019) (https://journals.sagepub.com/doi/pdf/10.1177/1535370219850787 ) reports that noninvasive imaging techniques can be used to study eye development. The study, led by Dr. Xincheng Yao , Richard and Loan Hill Professor of Bioengineering and Ophthalmology at the University of Illinois at Chicago in Chicago Illinois (USA), demonstrates that quantitative optical coherence tomography and angiography can be used to monitor the vascular system during eye development in mouse models. The hyaloid vascular system (HVS) is a transient circulatory system that nourishes the eyes in the ...

      Read Full Article
    12. Jefferson and Wills Eye Launch World's First Center Focused on Connections Between the Eye and the Brain

      Jefferson and Wills Eye Launch World's First Center Focused on Connections Between the Eye and the Brain

      Poets have called eyes the windows to the soul. Now, Jefferson and Wills Eye researchers will be able to use eyes as windows into debilitating diseases of the brain. Thomas Jefferson University , in partnership with Wills Eye Hospital and thanks to the generosity of several prescient philanthropists, has launched the world's first center focused on the visual signatures of neurological diseases. The William H. Annesley, Jr., MD '48 EyeBrain Center will explore the connections between the retina, optic nerve, and disorders of the brain, potentially revealing novel treatments for confounding diseases such as stroke, Alzheimer's, Parkinson's, multiple ...

      Read Full Article
    13. Optovue Launches New AngioWellness™ Scan at Vision Expo East

      Optovue Launches New AngioWellness™ Scan at Vision Expo East

      Optovue , the global leader in the development of optical coherence tomography (OCT) and OCT angiography (OCTA), will launch its new AngioWellness™ scan at Vision Expo East in New York , March 21-24, 2019 . The AngioWellness scan utilizes Optovue's advanced AngioVue ® OCTA technology to quickly assess and diagnose new pathologies in patients, including diabetic patients and those who may be at risk for glaucoma. Sample AngioWellness Report AngioWellness combines structural information on retinal and ganglion cell thickness with objective metrics on retinal vasculature into one easy-to-read report. The first of its kind patient-monitoring tool was designed to help eye care professionals ...

      Read Full Article
      Mentions: Visionix
    14. IEEE Elects Two NYU Tandon Professors as Fellows

      IEEE Elects Two NYU Tandon Professors as Fellows

      Gerig, who is affiliated with Tandon's Visualization, Image, and Data Analysis (VIDA) Center , has developed image analysis techniques for some of medicine's most challenging puzzles. His innovative methodologies – many of which are acknowledged to be the first of their kind – have been applied in a number of research studies on anatomical changes due to disease, therapy and recovery, as well as to such specific conditions as schizophrenia, autism, multiple sclerosis, and Huntington's disease. For example, as part of the Infant Brain Imaging Study, a landmark project funded by the National Institutes of Health (NIH) to identify babies ...

      Read Full Article
    15. Evidence Mounts That an Eye Scan May Detect Early Alzheimer's Disease

      Evidence Mounts That an Eye Scan May Detect Early Alzheimer's Disease

      Results from two studies show that a new, non-invasive imaging device can see signs of Alzheimer's disease in a matter of seconds. The researchers show that the small blood vessels in the retina at the back of the eye are altered in patients with Alzheimer's. Even patients who have a family history of Alzheimer's but have no symptoms show these telltale signs. And they showed that they can distinguish between people with Alzheimer's and those with only mild cognitive impairment. Results from these studies are being presented at AAO 2018, the 122 nd Annual Meeting of ...

      Read Full Article
      Mentions: Duke University
    16. Dr. Steven Galetta Recognized For Lifetime Achievement in Neurologic Education

      Dr. Steven Galetta Recognized For Lifetime Achievement in Neurologic Education

      Steven L. Galetta , MD , the Philip K. Moskowitz, MD Professor and Chair of Neurology at NYU Langone Health, has been awarded the 2018 A.B. Baker Award for Lifetime Achievement in Neurological Education by the American Academy of Neurology for his career contributions to the field. Dr. Galetta received this prestigious honor on Monday, April 23 , during the 2018 American Academy of Neurology Annual Meeting in Los Angeles, California .

      Read Full Article
    17. Novartis brolucizumab (RTH258) demonstrates superiority versus aflibercept in key secondary endpoint measures of disease activity in nAMD, a leading cause of blindness

      Novartis brolucizumab (RTH258) demonstrates superiority versus aflibercept in key secondary endpoint measures of disease activity in nAMD, a leading cause of blindness

      Novartis, a global leader in ophthalmology, announced further positive results from two Phase III studies of brolucizumab versus aflibercept. Results showed non-inferiority in primary endpoint, superiority in key retinal health outcomes, and long-lasting effect in patients with neovascular age-related macular degeneration (nAMD), a leading cause of blindness. The results of the head-to-head trials, HAWK and HARRIER, were presented at the American Academy of Ophthalmology (AAO) 2017 Annual Meeting 1 . In neovascular AMD, abnormal blood vessels leak fluid into the eye, ultimately causing damage and blindness 2 . At week 16, relative to aflibercept, 35% fewer brolucizumab 6 mg patients showed presence ...

      Read Full Article
    18. Notal Vision Celebrates 3 Millionth ForeseeHome® AMD Home-Monitoring Test

      Notal Vision Celebrates 3 Millionth ForeseeHome® AMD Home-Monitoring Test

      "Notal Vision has established a seamless, cloud-based infrastructure that connects healthcare providers and their patients through personalized, home-based monitoring designed to facilitate earlier ocular disease detection," said Quinton Oswald, Chief Executive Officer of Notal Vision. "ForeseeHome® uses a patented technology based upon Preferential Hyperacuity Perimetry (PHP) to identify minute changes in the central visual field before the patient notices any visual symptoms, and is the first application of Notal Vision's cloud-based monitoring platform. Notal Vision is developing a second product that will leverage the platform; home-based optical coherence tomography (OCT) testing. Notal Home OCT testing will generate an alert ...

      Read Full Article
      Mentions: Notal Vision
    19. New Digital Servo Driver Improves Speed and Precision for Laser Beam Steering

      New Digital Servo Driver Improves Speed and Precision for Laser Beam Steering

      ambridge Technology, a business unit of Novanta Corporation ("Novanta"), announced today the launch of the DC3000 Plus, a new digital servo driver, adding to its product family of components and scan heads for laser beam steering. The DC3000 Plus builds on the success of its predecessor, the DC3000, which applies digital state space controller technology to optimize speed in laser marking applications. With increased drive current and improved thermal management, the DC3000 Plus now offers higher marking speed and it accurately drives larger mirrors faster. These improvements expand the product line's capabilities in laser converting, micromachining, high power welding ...

      Read Full Article
    20. USC Roski Eye Institute experts present novel research in preventive care, diagnosis and treatment of visual impairment and eye diseases at ARVO Annual Meeting

      USC Roski Eye Institute experts present novel research in preventive care, diagnosis and treatment of visual impairment and eye diseases at ARVO Annual Meeting

      The experts at the University of Southern California (USC) Roski Eye Institute , who for 42 years have pursued novel research that address blinding eye diseases, will present their latest groundbreaking studies at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting held May 7-11 in Baltimore . "Research is at the heart of what we do at USC , it drives better preventive care, aids in improved diagnoses and creates innovative treatments that preserve, and in some cases, restore vision," said Rohit Varma , MD, MPH, dean of the Keck School of Medicine of USC and director of the USC Roski ...

      Read Full Article
    21. Zeiss AngioPlex Optical Coherence Tomography Angiography of the Retinal Microvasculature May Help Enhance Understanding of Retinal Diseas

      Zeiss AngioPlex Optical Coherence Tomography Angiography of the Retinal Microvasculature May Help Enhance Understanding of Retinal Diseas

      AngioPlexTM optical coherence tomography (OCT) is a new approach to diagnostic imaging in retinal disease. This technology uses amplitude and phase aspects of the OCT signal and novel algorithms to enable highly detailed visualisation of the retinal microvasculature. This system detects capillary flow rather than the presence of an injected dye. Unlike fluorescein angiography (FA), AngioPlex OCT imaging can discriminate capillaries at the superficial and deep retina and can also generate a colour map of the retinal vessels providing unparalleled views of diseased capillaries and net structures. Retinal and choroidal pathologies that are amenable to AngioPlex OCT examination include diabetic ...

      Read Full Article
      Mentions: FDA
    22. Leading Edge Collaboration in Eye-Related Research Earns Investigators at NYU Langone Medical Center, Johns Hopkins, and the UT Southwestern Medical Center the 2015 Barancik Prize for Innovation in MS Research

      Leading Edge Collaboration in Eye-Related Research Earns Investigators at NYU Langone Medical Center, Johns Hopkins, and the UT Southwestern Medical Center the 2015 Barancik Prize for Innovation in MS Research

      The collaborative team of Drs. Laura Balcer , Peter Calabresi and Elliot Frohman have been selected as the winners of the 2015 Barancik Prize for Innovation in MS Research. This team of physician-scientists have worked together for almost 10 years to produce novel, ground-breaking and impactful research about the anatomy and biology of the retina and other structures of the eye in people with multiple sclerosis (MS). In their more than 50 publications, the team has literally "written the book" when it comes to applying optical coherence tomography (OCT), a common and easy-to-use eye scanning technique, to study MS. Thanks in ...

      Read Full Article
    23. Study shows new technology may improve management of leading causes of blindness

      Study shows new technology may improve management of leading causes of blindness

      Research published today in the Proceedings of the National Academy of Sciences (PNAS) demonstrates that technology invented by researchers at Oregon Health & Science University's Casey Eye Institute can improve the clinical management of the leading causes of blindness. Optical coherence tomography (OCT) angiography could largely replace current dye-based angiography in the management of these diseases. OHSU researchers found that OCT angiography has considerable advantages over conventional techniques for the diagnosis and management of macular degeneration, diabetic eye disease and glaucoma, the leading causes of blindness in the United States . "This is a significant breakthrough technology that could fundamentally change ...

      Read Full Article
    1-24 of 89 1 2 3 4 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks